Advanced Biotechnologies, Inc. Company Profile

05:37 EST 18th December 2018 | BioPortfolio

ABI specializes in the development, manufacture, and supply of critical, value-added products and services for the research, monitoring, and infectious diseases. Through constant evaluation of the demanding field of scientific development, ABI has created a diverse product line. In addition to the collection of products listed in this catalog, ABI’s skilled research team delivers outstanding results on custom projects.

ABI’s state-of-the-art laboratories encompass 28,000 sq. ft. This workspace was designed around ABI’s concept of fully integrating the R&D, production, and purification of select human infectious disease etiologic agents. Resources available to our scientific team include Biosafety Level-3 laboratories for large-scale in vitro production of HIV and other critical viruses, supported internally by virology, protein purification, biochemistry, molecular biology, and microbiological quality control and assurance.


9108 Guilford Road
United States of America


Phone: 800-426-0764
Fax: 301-497-9773

News Articles [434 Associated News Articles listed on BioPortfolio]

DGAP-Stimmrechte: Elanix Biotechnologies AG (deutsch)

Elanix Biotechnologies AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung DGAP Stimmrechtsmitteilung: Elanix Biotechnologies AG Elanix Biotechnologies AG: Veröf...

DGAP-Gesamtstimmrechtsmitteilung: Elanix Biotechnologies AG (deutsch)

Elanix Biotechnologies AG: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 41 WpHG mit dem Ziel der europaweiten Verbreitung DGAP Gesamtstimmrechtsmitteilung: Elanix Biotechnologies AG / Ve.....

Deals this week: SQZ Biotechnologies, Immugenyx, Berkeley Lights

SQZ Biotechnologies has expanded its collaboration with Roche to develop products for oncology indications using cellular therapy. The two companies...Read More... The post Deals this week: SQZ Biotec...

DGAP-Adhoc: Elanix Biotechnologies AG: Widerruf der Bestellung von Herrn Tomas J. Svoboda (CEO) als Vorstandsmitglied (deutsch)

Elanix Biotechnologies AG: Widerruf der Bestellung von Herrn Tomas J. Svoboda (CEO) als Vorstandsmitglied DGAP-Ad-hoc: Elanix Biotechnologies AG / Schlagwort(e): Personalie Elanix Biotechnologies A...

DGAP-Adhoc: Elanix Biotechnologies AG: Frau Professor Laurent-Applegate, Gründerin und Interims-Vorstand, kündigt Verkauf von Aktien der Elanix Biotechnologies AG an (deutsch)

Elanix Biotechnologies AG: Frau Professor Laurent-Applegate, Gründerin und Interims-Vorstand, kündigt Verkauf von Aktien der Elanix Biotechnologies AG an DGAP-Ad-hoc: Elanix Biotechnologies AG / Sc....


$35.00End Date: Friday Aug-3-2018 5:25:47 PDTBuy It Now for only: $35.00Buy It Now | Add to watch list Biotech365 : INVITROGEN MOTHER E-BASE BY ETHROG BIOTECHNOLOGIES BioMarketplace You want to p...

Elanix Biotechnologies: Erfolgreiche Finanzierungsrunde

Ende Mai hat Elanix Biotechnologies eine Kapitalerhöhung angekündigt, heute kommt die Vollzugsmeldung der Berliner. Die Gesellschaft hat fast 0,68 Millionen Aktien ausgegeben. Der Bezugspreis je Ak....

Hoverink Biotechnologies, Inc., today announced that they have completed an application with the USPTO for MAXKAFLEN®. Hoverink Biotechnologies, Inc plans to develop and commercialize MAXKAFLEN® a cattle and swine antibiotic.

Overview LOS ANGELES, CA, Nov. 12, 2018 (GLOBE NEWSWIRE) -- On September 26, 2018 We filed trademark applications covering: MAXKAFLEN® Word Mark               MAXKAFLEN Goods and...

PubMed Articles [747 Associated PubMed Articles listed on BioPortfolio]

Biological sulfur oxidation in wastewater treatment: A review of emerging opportunities.

Sulfide prevails in both industrial and municipal waste streams and is one of the most troublesome issues with waste handling. Various technologies and strategies have been developed and used to deal ...

Neoadjuvant Crizotinib in Resectable Locally Advanced Non-Small-Cell Lung Cancer with ALK-rearrangement: A Brief Report.

Locally advanced non-small-cell lung cancer (NSCLC) is one of the most heterogeneous condition with multidimensional treatments involved. Neoadjuvant therapy was commonly considered as an optimal mana...

Contemporary management of advanced renal cell carcinoma.

Kidney cancer is the eighth most commonly diagnosed cancer in the United States, and nearly one-third of patients have locally advanced or metastatic disease at presentation. Historically, survival ou...

Peer support for people with advanced cancer: a systematically constructed scoping review of quantitative and qualitative evidence.

The number of people living with advanced cancer is increasing, and appropriate support to this population is essential. Peer support is increasingly advocated as a component of care, but little is kn...

Outcomes of Women Delivering at Very Advanced Maternal Age.

The purpose of this study was to evaluate the maternal outcome in women with very advanced maternal age (VAMA) at childbirth (>45 years) compared to advanced maternal age (35-39 and 40-44 years).

Clinical Trials [4829 Associated Clinical Trials listed on BioPortfolio]

Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies

The purpose of this study is to evaluate the safety, pharmacokinetics, pharmacodynamics and maximum tolerated dose of TAK-733 in patients with advanced, nonhematologic tumors. The expansi...

A Clinical Study to Compare MAR-CUTIS With Dermabond Advanced

This is a randomized, open-label, multicenter, comparator-controlled clinical study to compare MAR-CUTIS with Dermabond Advanced in closure of surgical incisions and lacerations ≤15 cm. ...

Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous

The purpose of Phase I of this study is to test the safety and tolerability of the investigational drug, OTS167, and that of Phase II of this study is to confirm the potential response ben...

Phase 1 Study of MKC-1 in Patients With Advanced Cancer

This is an open-label study to determine the highest dose of MKC-1 that may be administered daily on a continuous basis for patients with advanced or refractory solid tumors.

Advanced Care Management in Patients With Advanced Heart Failure

The purpose of this study is to explore the trajectory of advanced management care in patients with heart failure over a period of 9 months, then comparing the medical treatment accepted b...

Companies [871 Associated Companies listed on BioPortfolio]

RAN Biotechnologies

Based in Beverly, MA, USA, RAN Biotechnologies, Inc.,, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...

Glycos Biotechnologies, Inc.

Glycos Biotechnologies, Inc. (GlycosBio) is an emerging biochemical company pioneering the metabolic engineering of microbial strains to consume multiple non sugar-based, low valu...

Open Therapeutics

Open Therapeutics ( is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global ...

Genemed Biotechnologies Incorporated

Genemed Biotechnologies Inc. provides high quality contract manufacturing services for a wide variety of research and diagnostic products including native or recombinant proteins and nucleotides

NEXGEN Biotechnologies, Inc.

NEXGEN Biotechnologies, Inc. is the specialized 2nd Generation Plant Biotechnology company begun firstly in Korea.NEXGEN Biotechnologies, Inc., established in November 1999, is the venture biotechnolo...

More Information about "Advanced Biotechnologies, Inc." on BioPortfolio

We have published hundreds of Advanced Biotechnologies, Inc. news stories on BioPortfolio along with dozens of Advanced Biotechnologies, Inc. Clinical Trials and PubMed Articles about Advanced Biotechnologies, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Advanced Biotechnologies, Inc. Companies in our database. You can also find out about relevant Advanced Biotechnologies, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Corporate Database Quicklinks

Searches Linking to this Company Record